Câu trả lời ngắn gọn
The guide finds its target by matching about twenty letters, but the match does not have to be perfect. Somewhere else in three billion letters there may be a sequence close enough to fool it. Editing there is an off-target edit — and because the change is permanent, it stays. This is measured, not assumed: it is one of the things regulators look at most carefully.
Off-target editing occurs where a guide tolerates mismatches, particularly PAM-distal ones. It is assessed by genome-wide empirical methods — GUIDE-seq, CIRCLE-seq, DISCOVER-seq — combined with targeted deep sequencing of nominated sites in the edited product. Mitigation includes high-fidelity Cas variants, truncated guides, transient ribonucleoprotein delivery and, most fundamentally, choosing a target site with few genomic near-matches.
How much does it matter?
It depends entirely on where the off-target edit lands. Most of the genome does nothing in any given cell type, and a change there is likely harmless. An edit in a tumour suppressor gene is a different matter. This is why the question is never 'is there off-target editing' — there almost always is some — but 'where, how much, and does it matter in this tissue'.
It is also why delivery method matters for safety and not only for logistics: ribonucleoprotein delivered directly degrades within a day or two, while DNA encoding the editor may keep producing it for weeks, and every extra hour is more opportunity to cut the wrong place.
Try it: find a target the way a scientist would
Editing is not "point at a gene". The enzyme can only cut where a short tag sits beside the target, so the first job is finding legal positions. Paste any DNA sequence — or use the example — and this will scan both strands for you.
This is a teaching model of the first step only. A real design run also searches the whole genome for near-matches that could be cut by mistake, scores predicted efficiency, and is then confirmed by sequencing in cells — none of which can be done from a short sequence alone. The example is an illustrative sequence, not a real genomic locus.
Sources
- National Human Genome Research Institute
Talking Glossary of Genomic Terms ↗
Check your understanding — CRISPR basics
No score is stored and nothing is sent anywhere — this is just for you.
1. Which part of CRISPR-Cas9 do you actually change to target a different gene?
Why: Cas9 stays the same; the ~20-letter guide is the programmable part. That is the whole reason the technology spread so fast.
2. What is a PAM?
Why: No PAM, no cut — which means some positions in a gene simply cannot be reached with a given enzyme. It is a real constraint on what is targetable.
3. After Cas9 cuts, what most often happens?
Why: Rough end-joining dominates. That is why switching a gene OFF is reliable while correcting one letter is hard — and why base and prime editing were developed.
4. What does 'off-target' mean?
Why: Similar sequences elsewhere in the genome can be mistaken for the target. It is found by sequencing, and it is one of the main safety questions regulators ask about.